"As we celebrate this historic milestone, we're inspired by the extraordinary vision of MD Anderson's forefathers, and we remain focused on our mission to end cancer by disrupting the status quo with big ideas and bold initiatives like the Moon Shots Program," said Ronald A. DePinho, M.D., president of MD Anderson. "We're honored to welcome dignitaries from around the world, including Vice President Biden and Dr. Jill Biden, to reflect on our many breakthroughs and envision Making Cancer History. As cancer fighters, we're driven by boundless hope and optimism made possible with each scientific discovery, each clinical breakthrough and each new piece of knowledge disseminated. Knowledge is cancer's greatest vulnerability and its dissemination will make a meaningful impact on patients and their families."
MD Anderson's drive and innovation have led to lifesaving advances for patients around the globe. In 2012, MD Anderson launched the Moon Shots Program™, an institution-wide effort focused on rapidly and dramatically reducing mortality and suffering in cancer. In the program's first three years of implementation, researchers and clinicians have blazed new trails in translational research, making novel cancer therapies available to patients and beginning clinical trials in first-in-class drugs.
MD Anderson also enables patients to access its care, expertise and research-based approaches through collaborations with likeminded community hospitals, health systems and academic centers. The MD Anderson Cancer Network includes 24 institutions from California to New Jersey, and the institution's international work influences the cancer care of approximately one-third of the world's population.
"Cancer affects everyone. As the world's premier cancer center, we have a solemn responsibility to quickly share our knowledge to address this global program," said DePinho. "As we celebrate the outstanding work of our colleagues over the past 75 years, we also look to the future with enthusiasm during this golden era of cancer research. Now, more than ever, we have the opportunity to confine cancer to history for the generations to come."
To commemorate its diamond jubilee, the institution plans an array of festivities to recognize patients and survivors, donors, volunteers, employees and faculty members. The schedule of activities includes an employee recognition event, a cancer survivorship conference, the Boot Walk to End Cancer™, commemorated by a 75th anniversary boot ornament designed by MD Anderson's Children's Art Project, a faculty convocation, an employee service awards banquet and a gala dinner underwritten by Cooper University Health Care.
"In the fast-paced world of cancer research and care, anniversaries offer an opportunity to reflect on all that we've accomplished," said John Mendelsohn, M.D., MD Anderson's third full-time president and professor of Genomic Medicine. "MD Anderson is like no other institution in the world. The accomplishments made within its walls during the past 75 years are profound, and what is yet to come is unimaginable. We truly are Making Cancer History."
About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution's sole mission is to end cancer for patients and their families around the world. MD Anderson is one of only 45 comprehensive cancer centers designated by the National Cancer Institute (NCI). MD Anderson is ranked No.1 for cancer care in U.S. News & World Report's "Best Hospitals" survey. It has ranked as one of the nation's top two hospitals since the survey began in 1990, and has ranked first for nine of the past 10 years. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).
Logo - http://photos.prnewswire.com/prnh/20151113/287305LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/md-anderson-celebrates-75-years-of-making-cancer-history-300357905.html
SOURCE The University of Texas M. D. Anderson Cancer Center